Antibodies to Epstein-Barr Virus-Determined Antigens in Normal Subjects and in Patients with Seropositive Rheumatoid Arthritis
✍ Scribed by Michael A. Catalano, Dennis A. Carson, Susan F. Slovin, Douglas D. Richman and John H. Vaughan
- Book ID
- 123656188
- Publisher
- National Academy of Sciences
- Year
- 1979
- Tongue
- English
- Weight
- 660 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0027-8424
- DOI
- 10.2307/70552
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Antibodies to Epstein—Barr viral (EBV) antigens were studied in 12 patients with early (less than 6 weeks) rheumatoid arthritis (RA) and compared to controls. Geometric mean antibody titers to viral capsid antigen, early antigens, and Epstein—Barr‐associated nuclear antigen (EBNA) were
The incidence of antibodies to Epstein-Barr nucleair antigen type 2 (EBNA-2) was determined in sera from rheumatoid arthritis (RA) patients and control subjects, by protein immunoblotting. Sixty-eight percent of the RA patients and 48% of the controls possessed anti-EBNA-2 antibodies. The titer of a
## Abstract Antibody titers to Epstein‐Barr virus (EBV)‐specific antigens of 19 patients with hairy‐cell leukemia (HCL) were markedly elevated. All patients showed high titers of IgG anti‐viral capsid antigen (VCA) reactivity equal to or greater than 320 (reciprocal titer). The anti‐VCA reciprocal
Objective. A causative role for Epstein-Barr virus (EBV) in the development of lymphoma in patients with rheumatoid arthritis (RA) has been proposed. We investigated the molecular features of EBV-positive diffuse large cell lymphomas in 2 patients with RA. Methods. Southern blot analysis for immuno
We tested antibody titres against Epstein-Barr virus (EBV) antigens in patients sufrering rrom chronic viral disease and compared them with those determined in sexand age-matched healthy controls. Patient sera showed signs of active EBV infection [antibodies against earl) antigen (EA) and/or viral c